Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 2
2004 1
2012 1
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
A novel orally active inhibitor of HLE.
Varga M, Kapui Z, Bátori S, Nagy LT, Vasvári-Debreczy L, Mikus E, Urbán-Szabó K, Arányi P. Varga M, et al. Among authors: urban szabo k. Eur J Med Chem. 2003 Apr;38(4):421-5. doi: 10.1016/s0223-5234(03)00046-1. Eur J Med Chem. 2003. PMID: 12750030
Biochemical and pharmacological characterization of 2-(9-(2-piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a novel, orally active elastase inhibitor.
Kapui Z, Varga M, Urban-Szabo K, Mikus E, Szabo T, Szeredi J, Batori S, Finance O, Aranyi P. Kapui Z, et al. Among authors: urban szabo k. J Pharmacol Exp Ther. 2003 May;305(2):451-9. doi: 10.1124/jpet.102.044263. Epub 2003 Feb 11. J Pharmacol Exp Ther. 2003. PMID: 12606659
SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, Urban-Szabo K, Martinolle JP, Soubrié P, Finance O, Le Fur G. Gougat J, et al. Among authors: urban szabo k. J Pharmacol Exp Ther. 2004 May;309(2):661-9. doi: 10.1124/jpet.103.059527. Epub 2004 Jan 27. J Pharmacol Exp Ther. 2004. PMID: 14747609